Cerus (CERS) Capital Leases (2010)

Cerus (CERS) reported Capital Leases of $6000.0 for Q4 2010.

Cerus (CERS) Capital Leases (2010) Analysis & Trends

Cerus (CERS) has 1 years of Capital Leases data on file, last reported at $6000.0 in Q4 2010.

For the quarter ending Q4 2010, Capital Leases changed N/A year-over-year to $6000.0; the trailing twelve-month figure through Dec 2010 stood at $6000.0 (changed N/A YoY), and the FY2010 full-year result was $6000.0, changed N/A from the prior year.
Capital Leases was little changed at $6000.0 in Q4 2010.
In the past five years, Capital Leases ranged from a high of $6000.0 in Q4 2010 to a low of $6000.0 in Q4 2010.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	183.58 Bn	176.28 Bn	6.27 Bn
2	Stryker	129.01 Bn	126.13 Bn	3.81 Bn
3	Medtronic	108.52 Bn	99.30 Bn	6.41 Bn
4	Boston Scientific	68.67 Bn	67.22 Bn	3.61 Bn
5	Edwards Lifesciences	48.33 Bn	44.66 Bn	1.29 Bn
6	Dexcom	28.34 Bn	27.23 Bn	750.30 Mn
7	GE HealthCare Technologies	28.07 Bn	25.79 Bn	1.98 Bn
8	Smith & Nephew	26.89 Bn	26.31 Bn	-
9	Koninklijke Philips	24.12 Bn	21.00 Bn	2.07 Bn
10	Cerus	600.87 Mn	520.44 Mn	27.89 Mn

Historic Data

Download Data

Date	Value
Dec 31, 2010	6,000.00